|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108.
2005.
|
|
2
|
Eurosurveillance editorial team. WHO
launches the World Health Statistics 2012. Euro Surveill.
17:201752012.
|
|
3
|
Yang L: Incidence and mortality of gastric
cancer in China. World J Gastroenterol. 12:17–20. 2006.
|
|
4
|
Ladeiras-Lopes R, Pereira AK, Nogueira A,
et al: Smoking and gastric cancer: systematic review and
meta-analysis of cohort studies. Cancer Causes Control. 19:689–701.
2008.
|
|
5
|
Møller H, Heseltine E and Vainio H:
Working group report on schistosomes, liver flukes and Helicobacter
pylori. Int J Cancer. 60:587–589. 1995.
|
|
6
|
Bertuccio P, Rosato V, Andreano A, et al:
Dietary patterns and gastric cancer risk: a systematic review and
meta-analysis. Ann Oncol. 24:1450–1458. 2013.
|
|
7
|
Krech U: Complement-fixing antibodies
against cytomegalovirus in different parts of the world. Bull World
Health Organ. 49:103–106. 1973.
|
|
8
|
Dunn W, Chou C, Li H, et al: Functional
profiling of a human cytomegalovirus genome. Proc Natl Acad Sci
USA. 100:14223–14228. 2003.
|
|
9
|
Streblow DN, Orloff SL and Nelson JA: Do
pathogens accelerate atherosclerosis? J Nutr. 131:S2798–S2804.
2001.
|
|
10
|
Vasto S, Colonna-Romano G, Larbi A, Wikby
A, Caruso C and Pawelec G: Role of persistent CMV infection in
configuring T cell immunity in the elderly. Immun Ageing.
4:22007.
|
|
11
|
Rowshani AT, Bemelman FJ, van Leeuwen EM,
van Lier RA and ten Berge IJ: Clinical and immunologic aspects of
cytomegalovirus infection in solid organ transplant recipients.
Transplantation. 79:381–386. 2005.
|
|
12
|
Cheung TW and Teich SA: Cytomegalovirus
infection in patients with HIV infection. Mt Sinai J Med.
66:113–124. 1999.
|
|
13
|
Yi F, Zhao J, Luckheeram RV, et al: The
prevalence and risk factors of cytomegalovirus infection in
inflammatory bowel disease in Wuhan, Central China. Virol J.
10:432013.
|
|
14
|
Jang HJ, Kim AS and Hwang JB:
Cytomegalovirus-associated esophageal ulcer in an immunocompetent
infant: When should ganciclovir be administered? Korean J Pediatr.
55:491–493. 2012.
|
|
15
|
Chen HP, Jiang JK, Chen CY, et al: Human
cytomegalovirus preferentially infects the neoplastic epithelium of
colorectal cancer: a quantitative and histological analysis. J Clin
Virol. 54:240–244. 2012.
|
|
16
|
Samanta M, Harkins L, Klemm K, Britt WJ
and Cobbs CS: High prevalence of human cytomegalovirus in prostatic
intraepithelial neoplasia and prostatic carcinoma. J Urol.
170:998–1002. 2003.
|
|
17
|
Murphy E, Rigoutsos I, Shibuya T and Shenk
TE: Reevaluation of human cytomegalovirus coding potential. Proc
Natl Acad Sci USA. 100:13585–13590. 2003.
|
|
18
|
Grainger L, Cicchini L, Rak M, et al:
Stress-inducible alternative translation initiation of human
cytomegalovirus latency protein pUL138. J Virol. 84:9472–9486.
2010.
|
|
19
|
Petrucelli A, Umashankar M, Zagallo P, Rak
M and Goodrum F: Interactions between proteins encoded within the
human cytomegalovirus UL133–UL138 locus. J Virol. 86:8653–8662.
2012.
|
|
20
|
Umashankar M, Petrucelli A, Cicchini L, et
al: A novel human cytomegalovirus locus modulates cell
type-specific outcomes of infection. PLoS Pathog.
7:e10024442011.
|
|
21
|
Petrucelli A, Rak M, Grainger L and
Goodrum F: Characterization of a novel Golgi apparatus-localized
latency determinant encoded by human cytomegalovirus. J Virol.
83:5615–5629. 2009.
|
|
22
|
Taylor-Wiedeman J, Sissons P and Sinclair
J: Induction of endogenous human cytomegalovirus gene expression
after differentiation of monocytes from healthy carriers. J Virol.
68:1597–1604. 1994.
|
|
23
|
Reeves MB, MacAry PA, Lehner PJ, Sissons
JG and Sinclair JH: Latency, chromatin remodeling, and reactivation
of human cytomegalovirus in the dendritic cells of healthy
carriers. Proc Natl Acad Sci USA. 102:4140–4145. 2005.
|
|
24
|
Flucke U, Monig SP, Baldus SE, et al:
Differences between biopsy- or specimen-related Laurén and World
Health Organization classification in gastric cancer. World J Surg.
26:137–140. 2002.
|
|
25
|
Ajani JA, Bentrem DJ, Besh S, et al;
National Comprehensive Cancer Network. Gastric cancer, version
2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc
Netw. 11:531–546. 2013.
|
|
26
|
Lau SK, Chen YY, Chen WG, et al: Lack of
association of cytomegalovirus with human brain tumors. Mod Pathol.
18:838–843. 2005.
|
|
27
|
Harkins LE, Matlaf LA, Soroceanu L, et al:
Detection of human cytomegalovirus in normal and neoplastic breast
epithelium. Herpesviridae. 1:82010.
|
|
28
|
Cinatl J Jr, Cinatl J, Radsak K, et al:
Replication of human cytomegalovirus in a rhabdomyosarcoma cell
line depends on the state of differentiation of the cells. Arch
Virol. 138:391–401. 1994.
|
|
29
|
Nachmani D, Stern-Ginossar N, Sarid R and
Mandelboim O: Diverse herpesvirus microRNAs target the
stress-induced immune ligand MICB to escape recognition by natural
killer cells. Cell Host Microbe. 5:376–385. 2009.
|
|
30
|
Bego MG and St Jeor S: Human
cytomegalovirus infection of cells of hematopoietic origin:
HCMV-induced immunosuppression, immune evasion, and latency. Exp
Hematol. 34:555–570. 2006.
|
|
31
|
Qi Y, He R, Ma YP, Sun ZR, Ji YH and Ruan
Q: Human cytomegalovirus UL138 open reading frame is highly
conserved in clinical strains. Chin Med Sci J. 24:107–111.
2009.
|
|
32
|
Cinatl J, Scholz M, Kotchetkov R, Vogel JU
and Doerr HW: Molecular mechanisms of the modulatory effects of
HCMV infection in tumor cell biology. Trends Mol Med. 10:19–23.
2004.
|
|
33
|
Michaelis M, Doerr HW and Cinatl J: The
story of human cytomegalovirus and cancer: increasing evidence and
open questions. Neoplasia. 11:1–9. 2009.
|
|
34
|
Soroceanu L and Cobbs CS: Is HCMV a tumor
promoter? Virus Res. 157:193–203. 2011.
|
|
35
|
Cinatl J Jr, Vogel JU, Kotchetkov R and
Wilhelm Doerr H: Oncomodulatory signals by regulatory proteins
encoded by human cytomegalovirus: a novel role for viral infection
in tumor progression. FEMS Microbiol Rev. 28:59–77. 2004.
|
|
36
|
Chan G, Bivins-Smith ER, Smith MS and
Yurochko AD: NF-kappaB and phosphatidylinositol 3-kinase activity
mediates the HCMV-induced atypical M1/M2 polarization of monocytes.
Virus Res. 144:329–333. 2009.
|
|
37
|
Nachtwey J and Spencer JV: HCMV IL-10
suppresses cytokine expression in monocytes through inhibition of
nuclear factor-kappaB. Viral Immunol. 21:477–482. 2008.
|
|
38
|
Loenen WA, Bruggeman CA and Wiertz EJ:
Immune evasion by human cytomegalovirus: lessons in immunology and
cell biology. Semin Immunol. 13:41–49. 2001.
|
|
39
|
Michelson S: Human cytomegalovirus escape
from immune detection. Intervirology. 42:301–307. 1999.
|
|
40
|
Castillo JP and Kowalik TF: HCMV
infection: modulating the cell cycle and cell death. Int Rev
Immunol. 23:113–139. 2004.
|
|
41
|
Shen Y, Zhu H and Shenk T: Human
cytomagalovirus IE1 and IE2 proteins are mutagenic and mediate
‘hit-and-run’ oncogenic transformation in cooperation with the
adenovirus E1A proteins. Proc Natl Acad Sci USA. 94:3341–3345.
1997.
|
